Vericel Corporation
Cambridge, MA
- UEI
- WHK8B1525XA7
- CAGE
- 7GED2
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 64 Sidney St, Cambridge, MA 02139, USA
- Website
- vcel.com
- Founded
- 1989
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Maci final product assembled, 1 membrane | Veterans Integrated Service Network 1 | $76,400 | |
| Implant - surgical | Veterans Integrated Service Network 6 | $152,800 | |
| Pros knee cartilage defects | Veterans Integrated Service Network 19 | $69,772 | |
| Non surgical debridement | Office of the Assistant Secretary for Preparedness and Response | $34,880,933 | |
| Pros implants | Veterans Integrated Service Network 19 | $69,772 |
About Vericel Corporation
Vericel Corporation, a Cambridge, Massachusetts-based for-profit medical technology manufacturer, serves the federal government exclusively as a prime contractor (100% of recent awards) supplying advanced cell therapy products, cultured chondrocyte implants (MACI), and surgical membranes to the Department of Veterans Affairs and the Department of Health and Human Services. The vendor manufactures surgical appliances and supplies under NAICS 339113, competing full-and-open on all awards with no set-aside designations.
The vendor's recent footprint splits sharply between high-volume, low-value VA orthopedic supply contracts and a single transformational award from the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR/BARDA). That April 2026 definitive contract—valued at $191.8 million with a cost-plus-fixed-fee structure and a ten-year term extending through March 31, 2036—dwarfs all other activity. The contract establishes Vericel as the vendor-managed-inventory supplier of enzymatic debridement products designed for severe burn and blast trauma wounds during mass casualty incidents, with monthly reporting and rapid-deployment obligations under Project BioShield funding. This award represents a material expansion from Vericel's established VA footprint and anchors 97% of the vendor's combined potential value across all federal work.
The remaining 90 awards cluster with Veterans Integrated Service Networks (VISN) within VA's Veterans Health Administration. The top five customers by award count account for 77% of awards but only 3% of combined potential value: VISN 6 leads with 29 awards ($1.4 million combined), followed by VISN 12 (12 awards, $596 thousand), Army Medical Command (12 awards, $1.2 million), VISN 17 (9 awards, $414 thousand), and VISN 19 (8 awards, $474 thousand). These purchase orders are small (ranging from approximately $43 thousand to $111 thousand per award) and represent routine procurement of MACI implants, surgical membranes, and cartilage repair products for orthopedic and reconstructive procedures at individual VA medical centers. Activity in the VA channel has declined: nine awards in 2022, seven in 2023, eight in 2024, four in 2025, and four in 2026 year-to-date—a flattening trend despite the scale of the BARDA contract.
Combined potential value across 91 prime awards stands at $196.7 million, with $39.8 million (20%) currently obligated. The vendor carries no federal subcontract work and maintains no parent-vehicle positions on GWACs or BPAs. Within the next twenty-four months, recompete risk centers on the BARDA debridement contract—if recompeted—and the ongoing VISN purchase-order stream, though the latter carries modest individual values. Vericel's federal profile is dominated by a single high-value transaction with BARDA and a mature, declining VA supply relationship that dates to at least 2015.
Quick answers
What is Vericel Corporation's UEI?
Vericel Corporation's Unique Entity ID (UEI) in SAM.gov is WHK8B1525XA7.
What is Vericel Corporation's CAGE code?
Vericel Corporation's CAGE code is 7GED2.
What is Vericel Corporation's primary NAICS code?
Vericel Corporation's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Vericel Corporation located?
Vericel Corporation's physical address in SAM.gov is 64 Sidney St, Cambridge, MA 02139, USA.
Is Vericel Corporation registered in SAM.gov?
Yes. Vericel Corporation's SAM.gov registration is active through March 9, 2027.
What is Vericel Corporation's most recent federal award?
Vericel Corporation's most recent federal contract award is Maci final product assembled, 1 membrane (36C24126P0708), from Veterans Integrated Service Network 1, on September 3, 2026.
On GovTribe
See Vericel Corporation's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors